Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abrasion, acumen, Acuvue, Adjunct, advice, alert, amniotic, appeal, Armistice, aseptic, bacterial, Barbara, bioburden, Bioengineering, biographical, Boyd, Bromfenac, brought, Bulletin, chemotherapy, choose, CMHA, coincide, Columbia, comment, Condensed, constitute, Cornell, counsel, delisting, EMA, environment, error, ethical, EU, excise, exert, FCRP, Feesinclude, Feeswould, fellow, fellowship, filled, filter, forgiven, furniture, Garanzini, graph, Hackensack, heat, honesty, horizontally, husband, IDE, incumbent, ineffective, irradiation, Jersey, Johnson, jointly, leasehold, leveraging, Lexicon, lump, micro, microbiology, Moran, NEI, occupation, oflegislation, opting, Oxford, panel, passage, pattern, PE, pediatric, Pfizer, photophobia, pinpoint, Presbyterian, prorated, protein, provisional, quantify, red, reepithelization, regain, revalued, SAB, sealed, sensation, seventeen, simplification, sound, Steven, subsidy, successor, TCJA, territorial, thereon, thicker, tight, title, treasury, turn, unrepatriated, vehicle, vertically, viral, wear, Wirostko, withholding, Xalatan, York
Removed:
accretion, acting, advanced, appraisal, Bascom, curve, deduction, deferring, discouraging, extinguished, footnote, forfeiture, formal, growing, historically, impeding, lt, marketability, nursing, Palmer, publicly, repaid, representing, robust, screening, simple, Subtopic, takeover, tender, transscleral, underlie, underwriting, wider
Filing tables
Filing exhibits
EYEG similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of EyeGate Pharmaceuticals, Inc. on Form S-8 (Nos. 333-202207, 333-209441, and 333-216227) and on Form S-3 (No. 333-210557) of our report dated March 2, 2018, on our audits of the Consolidated Financial Statements as of December 31, 2017 and 2016 and for each of the years then ended, which report is included in this Annual Report on Form 10-K, to be filed on or about March 2, 2018. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern.
/s/ EisnerAmper LLP | |
EisnerAmper LLP | |
New York, New York | |
March 2, 2018 |